Gossamer Bio Inc (GOSS) — Cash Flow Reinvestment Rate

Latest as of June 2024: 1.51x

Gossamer Bio Inc (GOSS) has a Cash Flow Reinvestment Rate of 1.51x as of June 2024, reinvesting $175.46 Million (capex $116.35 Million plus investments $-59.11 Million) from operating cash flow of $116.35 Million. See Gossamer Bio Inc free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

1.51x
(Capex + Investments) / Operating CF

Total Reinvested

$175.46 Million
Capex + Investments

Operating Cash Flow

$116.35 Million
USD

Capital Expenditures

$116.35 Million
USD

Gossamer Bio Inc Cash Flow Reinvestment Rate (2016–2016)

Historical reinvestment intensity for Gossamer Bio Inc across 1 annual periods. For the full cash flow conversion analysis, see GOSS operating cash flow.

Annual Cash Flow Reinvestment Rate for Gossamer Bio Inc (2016–2016)

Year-by-year capital reinvestment analysis for Gossamer Bio Inc. See GOSS financial flexibility index to measure the company's free cash flow as a share of total liabilities.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2016 174.50x $3.49 Million $20.00K $3.49 Million —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow